Market Overview
| Study Period | 2020 - 2031 |
|---|---|
| Forecast Data Period | 2026 - 2031 |
| Historical Data Period | 2020 - 2024 |
| Base Year Market Size (2025) | USD 2.21 Billion |
| Market Size (2026) | USD 2.36 Billion |
| Market Size (2031) | USD 3.29 Billion |
| Growth Rate (2026 - 2031) | 6.83% CAGR |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Â鶹ÊÓƵ. Reuse requires attribution under CC BY 4.0. | |
Japan Patient Care Monitoring Equipment Market Analysis by Â鶹ÊÓƵ
The Japan Patient Care Monitoring Equipment market size is expected to grow from USD 2.21 billion in 2025 to USD 2.36 billion in 2026 and is forecast to reach USD 3.29 billion by 2031 at 6.83% CAGR over 2026-2031.
- The COVID-19 pandemic positively impacted market growth. The demand for wearable devices and patient monitoring devices has increased during the pandemic period as they allow contactless communication and tracking of medical conditions by clinicians. For instance, according to an article published by Mainichi Japan's National Daily in September 2021, it was observed that the demand for pulse oximetry increased in Japan due to the COVID-19 pandemic. The spread and early diagnosis of COVID-19 were determined through the remote monitoring of vital signs such as skin and body temperature, respiratory rate, pulse rate, heart rate, and blood oxygen level, which are related to COVID-19. Also, as per another article published in Nature Public Health Emergency Collection in February 2023, hypertensive patients were given a home blood pressure (BP) monitoring device that was connected to a web server, and local medical facilities were notified if their hypertensive patients had a consistent increase in BP levels in Japan. As per the World Health Organization (WHO) March 2023 update, 33.4 million confirmed cases of COVID-19 were reported in Japan. Thus, the increasing number of COVID-19 cases among the population is expected to increase the need to monitor oxygen levels, which is expected to increase the demand for patient monitoring devices such as oximetry and BP monitoring, which in turn fueled the market growth during the pandemic.
- Certain factors that are propelling the growth of the market are the rising burden of chronic diseases, such as neurological diseases, and the growing preference for home and remote monitoring devices. For instance, an article published in Clinical Parkonism & Related Disorder Journal in May 2022 stated that the prevalence rate of Parkinson's disease in the surveyed Japanese population was 279.7 per 100,000 individuals. Thus, the high burden of neurological diseases among Japanese people is expected to boost the need for regular monitoring to prevent health risks, which is expected to increase the demand for patient care monitoring devices, thereby accelerating the market growth.
- In addition, the rising geriatric population is also contributing to the growth of the studied market. For instance, according to the 2022 statistics published by the United Nations Population Fund, in Japan, a large proportion of the living population is aged 15-64 and accounts for 59% in 2022. In addition, as per the same source, 29% of the population is aged 65 years and above in 2022. Thus, the rising geriatric populations are more prone to develop chronic diseases that require proper monitoring and diagnosis, which is expected to increase the adoption of monitoring devices to regularly monitor their condition and status, thereby propelling the growth of the studied market.
- Furthermore, the rising company activities in developing advanced patient monitoring devices are also contributing to the market growth. For instance, in May 2021, Xenoma Inc., a Tokyo-based start-up spun off from the University of Tokyo, launched the e-skin Sleep T-shirt that is worn to bed to provide sleep diagnosis. The shirt comes with a small electronic device that is affixed to the pocket. The device can measure heartbeat, body movements, and temperature on the shirt's interior. The innovative technology is intended to assist patients with abnormal heart rhythms by more clearly documenting unexplained syncope.
- However, factors such as the resistance from healthcare professionals towards the adoption of patient monitoring systems and the high cost of technology are likely to restrain the market growth over the forecast period.
Note: Market size and forecast figures in this report are generated using Â鶹ÊÓƵ’s proprietary estimation framework, updated with the latest available data and insights as of 2026.
Japan Patient Care Monitoring Equipment Market Trends and Insights
Remote Patient Monitoring Devices are Expected to Show a Significant Growth Rate in the Japan Patient Care Monitoring Equipment Market Over The Forecast Period
- Remote patient monitoring (RPM) devices allow providers to monitor, report, and analyze their patient's acute or chronic conditions outside the hospital or clinic setting. They enable the practitioner to understand the patient's disease state and take preventative clinical actions.
- The remote patient monitoring segment is expected to witness significant growth over the forecast period owing to factors such as the rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, hypertension, respiratory diseases, neurological diseases, and others and the growing preference for home and remote monitoring. For instance, according to the International Diabetes Federation 2022 statistics, 11,005 thousand people in Japan were living with diabetes in 2021. In addition, this number is projected to reach 10,542.7 thousand by 2030. The high blood sugar caused by diabetes can damage the nerves that control the heart and blood vessels, leading to a variety of cardiovascular diseases like coronary artery disease and stroke, which can narrow the arteries. This is anticipated to raise the need for monitoring glucose levels, blood pressure, and other activities, which is expected to increase the demand for monitoring devices that can provide data to physicians to help them more effectively evaluate patient conditions and react quickly to any abnormalities, thereby propelling the market growth.
- Furthermore, according to an article published in November 2022 in the Journal of Medical Internet Research, telemonitoring is widely used to reduce mortality and improve self-management of chronic disease. Patients also report good satisfaction and adherence to a digital device for remote patient monitoring. Therefore, the growing adoption of telemonitoring and remote patient monitoring is expected to boost the segment's growth during the forecast period.
- Furthermore, the rising product launches are likely to contribute to the market growth over the forecast period. For instance, in March 2022, the Japanese Ministry of Health, Labour, and Welfare approved the expansion of reimbursement coverage for Abbott's FreeStyle Libre system to include all people with diabetes who use insulin at least once a day. The expanded coverage enables more people with diabetes to access the glucose data needed to manage their condition without the routine fingersticks associated with conventional blood glucose monitoring. Also, in July 2021, Terumo Corporation launched the Dexcom G6 continuous glucose monitoring (CGM) system, a medical device that supports diabetes control, in Japan. The system allows real-time glucose monitoring by using a compact, wearable sensor and transmitter to measure and automatically transfer glucose values wirelessly to a smart device or receiver every five minutes. Such launches and government initiatives are estimated to boost the demand for remote patient monitoring in the country during the analysis period.
- Therefore, due to the aforementioned factors, such as the high burden of chronic diseases, the adoption for remote patient monitoring, and the advantages offered, the segment is expected to witness healthy growth over the forecast period.
Cardiology Segment is Expected to Hold a Significant Market Share Over The Forecast Period
- Patient care monitoring equipment plays a vital role in the management and monitoring of cardiovascular diseases. The diseases include heart attack, stroke, cardiac arrhythmia, etc. Some of the equipment used in cardiological monitoring include cardiac rhythm management devices.
- A high burden of cardiovascular diseases in the country is likely to propel the growth of the segment over the analysis period. For instance, a research study published in BioMed Central Public Health Journal stated that in Japan, cardiovascular diseases (CVD) are among the top contributors to the disease burden that, accounts for over 20% of the total medical expenditure consumption in Japan. Also, the high burden of smoking in the country is associated with cardiovascular risks, thereby boosting the segment's growth. For instance, an article published in the Journal of Epidemiology in June 2021 reported the prevalence of smoking was 38.4% in Japan. Therefore, the high prevalence of CVD and smoking is projected to boost the usage of patient care monitoring equipment for the proper treatment and prevention of the condition, thereby propelling segment growth over the forecast period.
- Several market players are engaged in partnerships, launches, and acquisitions that support the market growth in the country. For instance, in September 2021, Astellas, Nitto Denko Corporation, and M. Heart Co., Ltd. collaborated to develop a solution for the early detection of atrial fibrillation using a disposable Holter ECG device and artificial intelligence (AI)-based Analysis Service. Such collaborations are projected to boost the usage of cardiovascular patient monitoring equipment in the country and propel the segment growth during the analysis period.
Competitive Landscape
The Japan patient monitoring market is fragmented. Some of the market players are Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., General Electric Company (GE Healthcare), Nihon Kohden Corporation, Siemens Healthcare GmBH, and others.
Japan Patient Care Monitoring Equipment Industry Leaders
Abbott Laboratories
General Electric Company (GE Healthcare)
Boston Scientific Corporation
Nihon Kohden Corporation
Koninklijke Philips N.V.
- *Disclaimer: Major Players sorted in no particular order
Market Opportunities and Future Outlook
Opportunities in Japan patient care monitoring equipment are increasingly linked to interoperable, software-driven workflows for home and remote care, along with hospital command-center models that consolidate bedside data. On the supply side, PMDA reinforced its Software as a Medical Device (SaMD) review capacity by reorganizing its SaMD Office on July 1, 2024. The SaMD guidance framework (administrative notice dated May 29, 2023, second version) also emphasizes practical approval-development considerations, including real-world data reliability and staged evidence generation. On the demand and operating-model side, MHLW documents around visit nursing digitization (online claim submission and online qualification confirmation starting in June 2024, with mandated use tied to the autumn 2024 timing of insurance card abolition) support more connected home-care workflows where remote monitoring devices can be integrated into routine care coordination.
The near-term gap is more scalable data connectivity and clinically anchored home monitoring programs that can move beyond single-facility pilots. In May 2026, SMFG, Fujitsu, and SoftBank announced a health and medical data foundation targeting use by up to 60 million users and introduction to 4,000 medical institutions. This initiative aligns with the government direction for a national medical information platform and creates a clearer pathway for monitoring-device data to flow into broader analytics and care management (subject to consent and platform governance). Company activity also points to cardiac home monitoring as an actionable use case. In February 2026, Shimadzu Future Innovation Fund invested in A-wave Inc., which is developing a wristwatch-type wearable that measures heart sounds at home for chronic heart failure patients, alongside a system for physicians to remotely access data. A-wave also disclosed a JPY 5.4 billion Series B and clinical research initiation at Osaka University Hospital, with preparation for nationwide clinical trial collaboration. These signals, together with Japan-specific standards expectations for central monitoring units (for example, alarm behavior and safety requirements referenced in IEC 60601-1-8 and related JIS standards), keep product differentiation focused on compliance-ready connectivity, alarm management, and integration with clinical information systems across acute and home settings.
Recent Industry Developments
- April 2026: Philips Japan started sales of the Flash 5100 POC series, an ultrasound imaging system specialized for point-of-care use in settings such as ICU and emergency departments. The launch supports workflow-centric acute care where monitoring, triage, and rapid decision-making increasingly occur at the bedside. This also reinforces Philips presence around connected critical-care environments.
- February 2026: Sapporo Medical University Hospital implemented an advanced remote ICU solution incorporating Philips eICU programs to link patient data from bedside monitors across facilities. This deployment reflects hospital demand for centralized oversight and cross-facility visibility. It also expands the integration surface for multi-parameter monitoring, alarms, and clinical decision support.
- October 2025: Philips Japan highlighted the importance of business continuity planning (BCP) at medical facilities during its Future Health Index 2025 Japan edition release seminar. The emphasis on BCP reinforces procurement interest in resilient monitoring and centralized visibility during disruptions. As a result, it influences how hospitals prioritize connected monitoring infrastructure and command-center type capabilities.
Research Methodology Framework and Report Scope
Market Definition and Coverage
This market covers the sales value of patient care monitoring equipment used in Japan to track vital signs and patient status, either at the bedside, in facilities, or through connected monitoring in home settings.
Scope exclusions: We exclude consumer-only wellness wearables with no clinical monitoring intent, as well as service-only remote monitoring programs when no equipment revenue is involved.
Segmentation Overview
- By Type of Device
- Hemodynamic Monitoring Devices
- Neuromonitoring Devices
- Cardiac Monitoring Devices
- Multi-parameter Monitors
- Respiratory Monitoring Devices
- Remote Patient Monitoring Devices
- Other Types of Devices
- By Application
- Cardiology
- Neurology
- Respiratory
- Fetal and Neonatal
- Weight Management and Fitness Monitoring
- Other Applications
- By End-Users
- Home Healthcare
- Hospitals and Clinics
- Other End-Users
Data Sources, Market Sizing, and Validation
Desk Research
Desk research set the base structure of the model, mainly by clarifying where demand sits and how equipment volumes tend to move across care settings in Japan. We used public health system and population indicators, and then mapped them to monitoring use cases in hospitals, clinics, and home care.
Sources referenced include public releases such as Japan Ministry of Health, Labour and Welfare statistics, OECD health data, World Health Organization datasets, UN population age structure series, and peer-reviewed clinical device adoption studies. We also reviewed company annual reports, investor presentations, product brochures, reputable medical news, and association websites to confirm product definitions and typical usage patterns. Where needed, a paid subscription covering company financials and a patent database were used to cross-check product pipelines and revenue directionality. The desk sources listed here are illustrative, and many other public documents were also used for data collection, validation, and clarification.
Primary Interviews and Surveys
Primary work focused on validating which monitoring categories are actively budgeted in Japan, how replacement cycles behave, and how quickly connected monitoring is being adopted across hospitals, clinics, and home healthcare. We spoke with a mix of manufacturers, distributors, and clinical and biomedical stakeholders so the gaps from desk research could be closed, and pricing and utilization assumptions could be pressure-tested before totals were finalized.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 31% | CXOs: 12% | |
| Mid tier: 49% | Functional/Unit leaders: 38% | |
| Smaller Players: 20% | Managers: 50% |
Market-Sizing & Forecasting
Sizing was built using a mixed approach that starts with a top-down demand pool reconstruction for Japan, and then is checked using selective bottom-up approximations. On the top-down side, we linked care delivery signals, such as hospital activity levels and the share of aging patients, to expected monitoring intensity by setting, followed by an adjustment for equipment replacement and upgrade cycles.
To keep the model practical, a short list of market fingerprints was used as key inputs, including the age 65-plus population trend, inpatient and outpatient procedure volumes, ICU and general ward monitoring penetration, home healthcare uptake for chronic conditions, and average selling price movements by device class. Forecasting was completed using scenario analysis supported by primary feedback on adoption speed and budget pressure, and then tuned so the curve reflects how procurement typically phases in over multi-year cycles. Where direct bottom-up rollups were not feasible, gaps were handled through proxy ratios, for example a sampled ASP times estimated unit shipments for selected device groups, then reconciled back to the total.
Data Validation & Update Cycle
Validation was done through multiple checks so the final values do not rely on a single assumption. We compared modeled totals against independent signals such as device category mix expectations, pricing direction, and the implied installed base replacement need, and then reviewed variances that looked too high or too low.
Before sign-off, the analysis is reviewed in steps, and experts are re-contacted when a major input changes or when the model produces an unexpected swing. Reports are refreshed annually, with interim updates when there are material events that can shift demand, pricing, or procurement behavior. Right before delivery, a final pass is done so clients receive an updated view based on the latest available information.
Â鶹ÊÓƵ's Japan Patient Care Monitoring Equipment Market Size Compared Against Other Published Estimates
Published market sizes for Japan patient care monitoring equipment can look different even when the topic sounds the same, because the counting rules are not always aligned. The most common differences come from what is treated as equipment revenue versus services, which device classes are bundled together, and which year is used as the starting point.
In our cross-checks, the largest gap drivers were whether remote patient monitoring is counted as hardware-only or as a broader program value, and whether pricing is assumed to rise evenly across categories despite mix shifts between multi-parameter, cardiac, respiratory, and fetal or neonatal use. Currency timing and refresh cadence also matter, and a narrower, device-revenue-only definition with category-level ASP and penetration checks explains why the 2025 figure lands where it does, followed by the more frequent assumption refresh applied by Â鶹ÊÓƵ.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Â鶹ÊÓƵ | USD 2.21 B (2025) | |
| Industry Publisher A | USD 2.10 B (2025) | Uses a slightly tighter device revenue scope in practice, which can undercount connected monitoring setups that are sold as bundled equipment packages across hospital and home channels. |
| Research House B | USD 2.26 B (2026) | Starts from a later year and includes broader monitoring programs and adjacent wearable and connected offerings, which tends to lift the total compared with a hardware-first equipment model. |
The spread in the table is mostly explained by timing, 2025 versus 2026, and by whether connected monitoring is treated as equipment sales only or as a wider care delivery spend line. By keeping the steps visible, using a small set of observable Japan demand signals, and validating assumptions with repeated primary checks, the resulting number stays traceable and easier to reproduce for planning discussions and budgeting.
Key Questions Answered in the Report
How big is the Japan Patient Care Monitoring Equipment Market?
The Japan Patient Care Monitoring Equipment Market size is expected to reach USD 2.36 billion in 2026 and grow at a CAGR of 6.83% to reach USD 3.29 billion by 2031.
What is the current Japan Patient Care Monitoring Equipment Market size?
In 2026, the Japan Patient Care Monitoring Equipment Market size is expected to reach USD 2.36 billion.
Who are the key players in Japan Patient Care Monitoring Equipment Market?
Abbott Laboratories, General Electric Company (GE Healthcare), Boston Scientific Corporation, Nihon Kohden Corporation and Koninklijke Philips N.V. are the major companies operating in the Japan Patient Care Monitoring Equipment Market.
What years does this Japan Patient Care Monitoring Equipment Market cover, and what was the market size in 2025?
In 2025, the Japan Patient Care Monitoring Equipment Market size was estimated at USD 2.36 billion. The report covers the Japan Patient Care Monitoring Equipment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Japan Patient Care Monitoring Equipment Market size for years: 2026, 2027, 2028, 2029, 2030 and 2031.
Page last updated on:
